BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35524377)

  • 1. Evaluating Mannuronic Acid Effect on Gene Expression Profile of Inflammatory Mediators in Rheumatoid Arthritis Patients.
    Omidian S; Aghazadeh Z; Ahmadzadeh A; Aslani M; Hosseini M; Abbasi S; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2022 Feb; 21(1):44-54. PubMed ID: 35524377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of β-D-mannuronic Acid, as a New Member of Non-steroidal Anti- Inflammatory Drugs Family, on the Expression Pattern of Chemokines and their Receptors in Rheumatoid Arthritis.
    Aslani M; Ahmadzadeh A; Aghazadeh Z; Zaki-Dizaji M; Sharifi L; Hosseini M; Mirshafiey A
    Curr Drug Discov Technol; 2021; 18(1):65-74. PubMed ID: 31657689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M2000 (β-D-Mannuronic Acid) as a Novel Antagonist for Blocking the TLR2 and TLR4 Downstream Signalling Pathway.
    Aletaha S; Haddad L; Roozbehkia M; Bigdeli R; Asgary V; Mahmoudi M; Mirshafiey A
    Scand J Immunol; 2017 Feb; 85(2):122-129. PubMed ID: 27943385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of β-D-Mannuronic Acid [M2000] on the Pro-Apoptotic Process and Inflammatory-Related Molecules NFκB, IL-8 and Cd49d using Healthy Donor PBMC.
    Khalatbari A; Mahdavi M; Jafarnezhad F; Afraei S; Zavareh FT; Aghazadeh Z; Ghaderi A; Mirshafiey A
    Curr Drug Discov Technol; 2020; 17(2):225-232. PubMed ID: 30417790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Mannuronic Acid on IL-1β, IL-17A, STAT1, and STAT3 Gene Expressions and TLR2 and TLR4 Molecules in Multiple Sclerosis.
    Najafi S; Saadat P; Beladi Moghadam N; Manoucherinia A; Aghazadeh Z; Vali Mohammadi A; Noorbakhsh SM; Movahedi M; Nikouei Moghaddam MR; Pashaiefar H; Mirshafiey A
    J Clin Pharmacol; 2022 Jun; 62(6):762-769. PubMed ID: 34825387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Oral Administration Effect of Drug Mannuronic Acid (M2000) on Gene Expression of Matrix and Tissue Inhibitor of Metalloproteinases in Rheumatoid Arthritis Patients.
    Gaafar NAG; Aslani M; Aghazadeh Z; Razavi A; Mirshafiey A
    Curr Drug Discov Technol; 2020; 17(5):704-710. PubMed ID: 31250758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of β-d-mannuronic acid, as a new non-steroidal anti-inflammatory drug on expression of miR-146a, IRAK1, TRAF6, NF-κB and pro-inflammatory cytokines following a clinical trial in rheumatoid arthritis patients.
    Mortazavi-Jahromi SS; Ahmadzadeh A; Rezaieyazdi Z; Aslani M; Omidian S; Mirshafiey A
    Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):228-236. PubMed ID: 32223462
    [No Abstract]   [Full Text] [Related]  

  • 8. An in vitro assessment for evaluating the efficiency of β-d-mannuronic acid (M2000) in myelodysplastic syndrome.
    Bakhtiari T; Ghaderi A; Safaee Nodehi SR; Aghazadeh Z; Tofighi Zavareh F; Jafarnezhad-Ansariha F; Barati A; Mirshafiey A
    J Cell Physiol; 2019 Aug; 234(8):12971-12977. PubMed ID: 30537258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematological Improvement of Patients with Active Rheumatoid Arthritis by β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property.
    Ahmadi H; Jamshidi AR; Mahmoudi M; Gharibdoost F; Vojdanian M; Fattahi MJ; Rastkari N; Aghazadeh Z; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2017 Oct; 16(5):433-442. PubMed ID: 29149783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopharmacological effect of β-d-mannuronic acid (M2000), as a new immunosuppressive drug, on gene expression of miR-155 and its target molecules (SOCS1, SHIP1) in a clinical trial on rheumatoid arthritis patients.
    Mortazavi-Jahromi SS; Aslani M; Omidian S; Ahmadzadeh A; Rezaieyazdi Z; Mirshafiey A
    Drug Dev Res; 2020 May; 81(3):295-304. PubMed ID: 31675124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Inhibitory Role of M2000 (β-D-Mannuronic Acid) on Expression of Toll-like Receptor 2 and 4 in HT29 Cell Line.
    Sharifi L; Moshiri M; Dallal MMS; Asgardoon MH; Nourizadeh M; Bokaie S; Mirshafiey A
    Recent Pat Inflamm Allergy Drug Discov; 2019; 13(1):57-65. PubMed ID: 30539708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mannuronic acid (M2000) on gene expression profile of signal transducer and activator of transcription proteins (STATs) in rheumatoid arthritis patients.
    Gaafar NAG; Aslani M; Aghazadeh Z; Mortazavi-Jahromi SS; Razavi A; Mirshafiey A
    Reumatismo; 2020 Jul; 72(2):93-102. PubMed ID: 32700875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients.
    Xu L; Feng X; Tan W; Gu W; Guo D; Zhang M; Wang F
    Arthritis Res Ther; 2013 Oct; 15(5):R170. PubMed ID: 24286242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of β-d-mannuronic acid, as a novel non-steroidal anti-inflammatory medication within immunosuppressive properties, on
    Barati A; Jamshidi AR; Ahmadi H; Aghazadeh Z; Mirshafiey A
    Drug Des Devel Ther; 2017; 11():1027-1033. PubMed ID: 28408801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Situation of Chemokine Ligands and Receptors Gene Expression, Following the Oral Administration of Drug Mannuronic Acid in Rheumatoid Arthritis Patients.
    Aslani M; Ahmadzadeh A; Rezaieyazdi Z; Mortazavi-Jahromi SS; Barati A; Hosseini M; Mirshafiey A
    Recent Pat Inflamm Allergy Drug Discov; 2020; 14(1):69-77. PubMed ID: 31729947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of circulating Th17 cells by β-D-mannuronic acid (M2000) as a novel medication in patients with rheumatoid arthritis.
    Ahmadi H; Mahmoudi M; Gharibdoost F; Vojdanian M; Jamshidi AR; Fattahi MJ; Aghazadeh Z; Barati A; Mirshafiey A
    Inflammopharmacology; 2018 Feb; 26(1):57-65. PubMed ID: 29063487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor effect of M2000 (β-d-mannuronic acid) on the expression of inflammatory molecules in the prostate cancer cell.
    Mohsenzadegan M; Moghbeli F; Mirshafiey A; Farajollahi MM
    Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):419-430. PubMed ID: 34057866
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunomodulatory Effect of G2013 (α-L-Guluronic Acid) on the TLR2 and TLR4 in Human Mononuclear Cells.
    Sharifi L; Mohsenzadegan M; Aghamohammadi A; Rezaei N; Zavareh FT; Bokaie S; Moshiri M; Aghazadeh Z; Norouzbabaie Z; Azizi G; Mirshafiey A
    Curr Drug Discov Technol; 2018; 15(2):123-131. PubMed ID: 28578651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-D-mannuronic Acid (M2000) and Inflammatory Cytokines in COVID-19; An In vitro Study.
    Robat-Jazi B; Ghorban K; Gholami M; Samizadeh E; Aghazadeh Z; Shahrbaf MA; Dadmanesh M; Hosseini Rouzbahani N; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2022 Dec; 21(6):677-686. PubMed ID: 36640059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potent suppressive effect of β-d-mannuronic acid (M2000) on molecular expression of the TLR/NF-kB Signaling Pathway in ankylosing spondylitis patients.
    Roozbehkia M; Mahmoudi M; Aletaha S; Rezaei N; Fattahi MJ; Jafarnezhad-Ansariha F; Barati A; Mirshafiey A
    Int Immunopharmacol; 2017 Nov; 52():191-196. PubMed ID: 28938189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.